Skip to main content

Curaleaf Holdings, Inc.

CURLF
Exchange
OTC
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001756770

No open-market purchases or sales by Curaleaf Holdings, Inc. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $134.7M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Curaleaf Holdings, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of CURLF: Q4 2023 compared with Q1 2024
MeasureQ4 2023Of which not filed for Q1 2024Q1 2024Change
Holders12211+1
Shares163.1K3.20K9.48M+9.32M (+5,827.4%)
Value$635.1K$13.4K$51.9M+$51.3M (+8,252.1%)

2 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held Curaleaf Holdings, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to CURLF in Q1 2024
InstitutionSharesValue% of portfolio
AdvisorShares Investments LLC9,352,610$51.3M8.64%
Canton Hathaway, LLC7,600$41.0K0.01%
AlphaMark Advisors, LLC600$3.00K0.00%
Horizon Financial Services, LLC550$2.94K0.00%

Sold out (3)

Institutions that held Curaleaf Holdings, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of CURLF in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Partners Capital Investment Group, LLP38,723$157.2K
Bartlett & Co. Wealth Management LLC3,100$12.7K
Operose Advisors LLC2,000$8.12K

Not filed for Q1 2024 yet (2)

Institutions that held Curaleaf Holdings, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CURLF in Q4 2023 that haven't filed for Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Bartlett & Co. LLC3,100$13.0K
Strategic Investment Solutions, Inc.100$406